ClaimQI Raises Nearly $500K for Claims Intelligence

The most expensive gap in healthcare payment integrity can be one line wide: the distance between a coverage rule and the claim decision it was supposed to govern. Flagging a transaction as unusual is useful, but a payer still needs to explain what is wrong, which rule applies, and why the determination should survive a provider dispute or audit.

ClaimQI has raised just under $500K to build around that gap. The Omaha healthcare claims-intelligence company announced the Seed close on September 8, 2026, with CQuence Health and four unnamed private investors participating.

The capital arrives as ClaimQI brings its Platform and Payer Portal to Medicare payers. The company's operating thesis is unusually specific for a young AI business: use language models to translate the complexity inside policies and codes, then anchor each claim determination in deterministic rules and source material rather than letting the language model make the hard decision.

What ClaimQI Closed and What Remains Pending

ClaimQI's official announcement describes the financing as a closed Seed round of just under $500K. CQuence Health separately confirmed its investment and strategic support, while ClaimQI said four private investors also joined. No lead investor, exact round amount, security, valuation, ownership percentage, board rights, or individual check sizes were disclosed.

A separate $150K Innovation and Prototype grant from the Nebraska Department of Economic Development remains subject to final approval. That distinction matters: pending public support is not cash already raised, so the grant should not be added to the Seed total. Nebraska's Prototype Grant guidelines describe a reimbursement-based program with approval, matching-fund, and eligible-expense conditions.

ClaimQI says it will use the Seed capital to scale its Platform and Payer Portal and expand across Medicare Advantage, Medicaid, Medigap, and self-funded ERISA markets. The company scheduled a formal launch for Medicare payers on September 9 at the Healthcare Payment & Revenue Integrity Congress in Chicago, where it is participating as a Community Partner.

Why ClaimQI Separates AI From the Determination

Healthcare claims do not fail for one clean reason. Coverage policies, billing codes, documentation, benefit design, provider relationships, and timing can all change whether a payment is proper. A probabilistic score may help a team decide where to look, but it does not automatically supply the policy-linked explanation needed to deny, recover, or defend a payment decision.

ClaimQI says its system uses machine learning and large language models to translate complex coverage documents and codes into deterministic, executable rule logic. Its ClaimQI Core product page says the LLM does not process claims or make hard determinations, and that protected claims data does not enter the language-model dataset. The platform is designed to return explanations, source citations, and configurable controls alongside claim results.

That division of labor is the company's most consequential product choice. Language models are good at parsing dense text and connecting concepts, but payer decisions require consistency, traceability, and governance. ClaimQI is trying to use the flexible part of AI to organize the rules while keeping the accountable part of the workflow explicit enough for a human, provider, or auditor to inspect.

The company also describes ClaimQI Prevent as a layer that uses anomaly and association analysis to prioritize higher-risk cases. ClaimQI has filed a U.S. patent application covering its underlying approach, but it has not disclosed the application number or provided independent validation of product accuracy or savings.

The Founders and the CQuence Hand-Off

Chad J. Wells, ClaimQI's co-founder, President and CEO, brings health-plan product, P&L, pricing, distribution, and go-to-market experience. Janna Hart, co-founder and Chief Operating & Product Officer, brings more than 20 years in Medicare claims analytics, audits, data science, clinical coding, coverage, and fraud, waste, and abuse detection. ClaimQI says their combined experience exceeds 50 years.

That background matters because the company is selling into a workflow where technical output becomes financial and regulatory evidence. A model can identify a pattern in seconds, but the buyer must integrate that output with claims operations, provider communication, recovery teams, Special Investigations Units, compliance processes, and existing adjudication controls.

CQuence Health's role extends beyond its undisclosed investment. The employee-owned Omaha healthcare strategy firm provides portfolio companies with professional services, operating guidance, and industry relationships. For ClaimQI, that support can help with the work between product launch and repeatable payer adoption: implementation, security, commercial positioning, and the institutional trust required to put a new system near claim decisions.

A Large Market That Requires Precise Accounting

The market problem is real, but the language around it is often sloppy. The Centers for Medicare & Medicaid Services reported a FY2025 Medicare Part C improper-payment estimate of $23.67B, equal to 6.09% of the payments measured for payment year 2023. CMS explicitly says improper-payment measurement is not a fraud measure.

Improper payments can include overpayments, underpayments, missing documentation, and failures to meet program requirements. Fraud is part of the wider payment-integrity problem, but the two categories cannot be treated as synonyms. That boundary strengthens ClaimQI's opportunity rather than weakening it: payers need systems that can explain different kinds of errors without turning every irregular claim into an accusation.

Moving the analysis earlier could change the economics of the work. Post-payment recovery requires plans and providers to revisit money that has already moved, often through audits, appeals, documentation requests, and collection processes. A source-linked decision before payment may reduce that administrative loop, provided the system is accurate enough to avoid creating a new one.

What the Seed Now Has to Prove

ClaimQI has not disclosed customers, revenue, production claim volume, previous financing, total funding, or independently audited performance. CQuence Health says SOC 2 certification is in progress, which means the security evidence is still being assembled rather than completed. The Nebraska grant is also still pending final approval.

Those are normal gaps for an early company, but they define the work the Seed must finance. ClaimQI needs to show that policy translation remains current as rules change, deterministic logic produces consistent results, source citations are usable by claims teams, and integrations fit the operational systems where payers already work. It must also prove that moving detection upstream produces measurable savings without simply moving review burden to a different queue.

The September launch puts ClaimQI's design choice in front of the people who live with that burden. If the platform can turn policy language into claim-level evidence without asking a language model to make the final call, the company will have more than an AI feature. It will have a way to make each payment-integrity decision arrive with the explanation the buyer needs to act on it.